Research

Tape measure helix
Health

A new genetic test can offer clues — and only clues — to a person’s risk of obesity

By Rebecca Robbins

Unfinished bridge
Biotech

When a new biotech’s drug pipeline is more of a ‘hypeline’

By Kate Sheridan

Morrisey STM image
In the Lab

CRISPR edits lung-disease gene in utero, hitting only the affected organ in a mouse study

By Sharon Begley

Pig
In the Lab

The pigs were dead. But four hours later, scientists restored cellular functions in their brains

By Sharon Begley

High Blood Pressure
Health

For its next phase, the Framingham Heart Study will explore the biology of aging

By Robert Weisman — Boston Globe

Man coughing
Biotech

How one company thinks unraveling cough can provide a new way to treat pain

By Damian Garde

He Jiankui speaks in HK
In the Lab

Stanford clears three faculty members of ‘CRISPR babies’ involvement

By Sharon Begley

Daphne Koller
Biotech

In a test for AI, a buzzy machine learning startup inks drug discovery deal with Gilead

By Matthew Herper and Rebecca Robbins

Mice, the problem with
First Opinion

The trouble with mice as behavioral models for Alzheimer’s and other neurologic diseases

By Adam Rosenberg

Pile of mice
In the Lab

It’s just in mice! This scientist is calling out hype in science reporting

By Shraddha Chakradhar

Prostate Cancer Cell
Health

The study of a cancer test seemed like a triumph. But some data were missing

By Eric Boodman

Scott Kelly, Mark Kelly
Health

NASA twins study explores body’s response to long space travel

By Associated Press

Ketamine Depression
Health

Scientists still don’t know what gives ketamine its antidepressant effect. Stressed mice might offer a clue

By Megan Thielking

Flora of small intestine
Biotech

As microbiome companies develop new therapies, it’s academics who are doing the heavy lifting

By Kate Sheridan

Can opener
In the Lab

New study reveals HIV’s vulnerabilities, opening up possibilities for complementary therapies

By Shraddha Chakradhar

headquarters of Verily Life Sciences
Business

5 names to know at Verily: Players to watch at Alphabet’s life sciences unit

By Rebecca Robbins

MRSA
First Opinion

Creating new antimicrobial drugs will require governments working with industry

By Thomas B. Cueni

Michigan Medicine
In the Lab

Michigan tops STAT Madness voting with a potential treatment for tinnitus

By Elizabeth Cooney

Jaenisch-Liu
In the Lab

In STAT Madness, CRISPR tools to treat brain disorders capture Editors’ Pick

By Sharon Begley

Your Health Speaks
Health

In the quest to turn voice data into a depression screening tool, one startup looks to India

By Rebecca Robbins

Couple holding hands
Health

Your sexual partners can change your microbiome, a new study in mice finds

By Kate Sheridan

Breastfeeding mother and baby
Health

Breastfeeding women need to know more about the risks of taking medication, experts say

By Megan Thielking

Peter Bucciarelli
Health

Hepatitis C-infected hearts and lungs can be safely transplanted, study says, opening way to more donors

By Jacquelyn Corley

UCLA campus
Go West

Staff scientists at the University of California set to form a first-of-its-kind union

By Rebecca Robbins

Probiotics illustration
Health

Probiotics are touted as good for the gut. They may be trouble for the immune system

By Meghana Keshavan

Biotech

It’s only test tubes and mice, but Rubius Therapeutics hails first new data on red blood cell-derived cancer drugs

By Adam Feuerstein

Biotech

In biotech’s biggest hub, companies open their labs to an unlikely inspector: the city’s veterinarian

By Kate Sheridan

Health

When the ‘real thing’ becomes a mirage: How patients in Alzheimer’s trials are coping with the treatment’s failure

By Andrew Joseph

Health

Genomes of mosquito, mulberry, and other organisms help reveal how life works

By Associated Press

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy